Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, and electrophoresis. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal, aquatic-bio, mosquito-borne, and plant diseases, as well as food safety, human pathogen, and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.
Metrics to compare | 064550 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship064550PeersSector | |
---|---|---|---|---|
P/E Ratio | −19.1x | −8.6x | −0.5x | |
PEG Ratio | 0.23 | −0.07 | 0.00 | |
Price/Book | 1.8x | 2.7x | 2.6x | |
Price / LTM Sales | 1.3x | 19.8x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.5% | |
Fair Value Upside | Unlock | 8.1% | 6.9% | Unlock |